FMCSA Reviews 11 Epilepsy Waivers for Commercial Drivers

The Federal Motor Carrier Safety Administration is evaluating 11 applications from individuals seeking medical exemptions to operate commercial vehicles despite documented seizure histories. S. states, have maintained seizure-free periods ranging from nearly seven years to over two decades, with most continuing anti-seizure medication under physician supervision. This represents a routine cycle of the FMCSA's established epilepsy exemption program, which has operated since 2013 and approved 14 such waivers in 2024 alone.

For supply chain and logistics professionals, this development signals the ongoing evolution of driver qualification standards in response to medical advancements and individual risk assessment. While individual waivers have minimal direct operational impact, the broader trend reflects a gradual liberalization of medical barriers to entry in commercial trucking—a sector facing persistent driver shortages. Each approved exemption marginally expands the addressable labor pool, though the incremental effect remains modest given the hundreds of thousands of commercial drivers in active operation. The public comment period, closing June 29, 2026, allows stakeholders to flag safety concerns or support expanded access.

For logistics operators, understanding this regulatory landscape matters for long-term workforce planning and recruitment strategy, particularly as the industry continues to grapple with capacity constraints. The FMCSA's deliberate, evidence-based approach to individual medical exemptions—grounded in seizure-free duration, stable medication regimens, and physician endorsement—suggests the agency is unlikely to substantially relax eligibility criteria, keeping structural labor supply dynamics relatively stable.